                         SEQUENCE LISTING

<110>  THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
 
<120>  COMPOSITIONS AND METHODS FOR THE TREATMENT OF OCULAR 
       NEUROINFLAMMATION

<130>  0321.142981PCT/SD2021-050-1

<140>  PCT/US2021/047569
<141>  2021-08-25

<150>  63/070,145
<151>  2020-08-25

<160>  18    

<170>  PatentIn version 3.5

<210>  1
<211>  22
<212>  DNA
<213>  artificial sequence

<220>
<223>  synthetic nucleotide

<400>  1
gacgagctgt atgagctggt gg                                                22


<210>  2
<211>  23
<212>  DNA
<213>  artificial sequence

<220>
<223>  synthetic oligonucleotide

<400>  2
ctgtagacgg tagacacact ctg                                               23


<210>  3
<211>  21
<212>  DNA
<213>  artificial sequence

<220>
<223>  synthetic oligonucleotide

<400>  3
tggagagcac caagacagac a                                                 21


<210>  4
<211>  19
<212>  DNA
<213>  artificial sequence

<220>
<223>  synthetic oligonucleotide

<400>  4
tgccggagtc gacaatgat                                                    19


<210>  5
<211>  21
<212>  DNA
<213>  artificial sequence

<220>
<223>  synthetic oligonucleotide

<400>  5
gcgcagaact ctagctgtaa t                                                 21


<210>  6
<211>  22
<212>  DNA
<213>  artificial sequence

<220>
<223>  synthetic oligonucleotide

<400>  6
ctggaataac ccttcccatc aa                                                22


<210>  7
<211>  21
<212>  DNA
<213>  artificial sequence

<220>
<223>  synthetic oligonucleotide

<400>  7
caagaccggc tgaggtttat t                                                 21


<210>  8
<211>  22
<212>  DNA
<213>  artificial sequence

<220>
<223>  synthetic oligonucletide

<400>  8
cctttccact tcctccgtaa tc                                                22


<210>  9
<211>  20
<212>  DNA
<213>  artificial sequence

<220>
<223>  synthetic oligonucleotide

<400>  9
gcccaatgtc actcactact                                                   20


<210>  10
<211>  22
<212>  DNA
<213>  artificial sequence

<220>
<223>  synthetic oligonucleotide

<400>  10
cccgtcgatg ttctgtgtat ag                                                22


<210>  11
<211>  22
<212>  DNA
<213>  artificial sequence

<220>
<223>  synthetic oligonucleotide

<400>  11
ctcccgactt ggacaagatt ac                                                22


<210>  12
<211>  22
<212>  DNA
<213>  artificial sequence

<220>
<223>  synthetic oligonucleotide

<400>  12
ccatgatctg ttgctcgaaa tg                                                22


<210>  13
<211>  21
<212>  DNA
<213>  artificial sequence

<220>
<223>  synthetic oligonucleotide

<400>  13
gcccaatgtc actcactact t                                                 21


<210>  14
<211>  22
<212>  DNA
<213>  artificial sequence

<220>
<223>  synthetic oligonucleotide

<400>  14
cccgtcgatg ttctgtgtat ag                                                22


<210>  15
<211>  19
<212>  DNA
<213>  artificial sequence

<220>
<223>  synthetic oligonucleotide

<400>  15
agcgtgactt tgggtcttt                                                    19


<210>  16
<211>  20
<212>  DNA
<213>  artificial sequence

<220>
<223>  synthetic oligonucleotide

<400>  16
agcgaccttg ctccttattg                                                   20


<210>  17
<211>  1121
<212>  DNA
<213>  homo sapiens

<400>  17
gggccgggcc gggccggggg cgcgcgctct gcgagctgga tgtccaggct gcgggcgctg       60

ctgggcctcg ggctgctggt tgcgggctcg cgcgtgccgc ggatcaaaag ccagaccatc      120

gcctgtcgct cgggacccac ctggtgggga ccgcagcggc tgaactcggg tggccgctgg      180

gactcagagg tcatggcgag cacggtggtg aagtacctga gccaggagga ggcccaggcc      240

gtggaccagg agctatttaa cgaataccag ttcagcgtgg accaacttat ggaactggcc      300

gggctgagct gtgctacagc catcgccaag gcatatcccc ccacgtccat gtccaggagc      360

ccccctactg tcctggtcat ctgtggcccg gggaataatg gaggagatgg tctggtctgt      420

gctcgacacc tcaaactctt tggctacgag ccaaccatct attaccccaa aaggcctaac      480

aagcccctct tcactgcatt ggtgacccag tgtcagaaaa tggacatccc tttccttggg      540

gaaatgcccg cagagcccat gacgattgat gaactgtatg agctggtggt ggatgccatc      600

tttggcttca gcttcaaggg cgatgttcgg gaaccgttcc acagcatcct gagtgtcctg      660

aagggactca ctgtgcccat tgccagcatc gacattccct caggatggga cgtggagaag      720

ggaaatgctg gagggatcca gccagacttg ctcatatccc tcacagcccc caaaaaatct      780

gcaacccagt ttaccggtcg ctaccattac ctggggggtc gttttgtgcc acctgctctg      840

gagaagaagt accagctgaa cctgccaccc taccctgaca ccgagtgtgt ctatcgtctg      900

cagtgaggga aggtgggtgg gtattcttcc caataaagac ttagagcccc tctcttccag      960

aactgtggat tcctgggagc tcctctggca ataaaagtca gtgaatggtg gaagtcagag     1020

accaaccctg gggattgggt gccatctctc taggggtaac acaaagggca agaggttgct     1080

atggtatttg gaaacaatga aaatggactg ttagatgcca a                         1121


<210>  18
<211>  288
<212>  PRT
<213>  homo sapiens

<400>  18

Met Ser Arg Leu Arg Ala Leu Leu Gly Leu Gly Leu Leu Val Ala Gly 
1               5                   10                  15      


Ser Arg Val Pro Arg Ile Lys Ser Gln Thr Ile Ala Cys Arg Ser Gly 
            20                  25                  30          


Pro Thr Trp Trp Gly Pro Gln Arg Leu Asn Ser Gly Gly Arg Trp Asp 
        35                  40                  45              


Ser Glu Val Met Ala Ser Thr Val Val Lys Tyr Leu Ser Gln Glu Glu 
    50                  55                  60                  


Ala Gln Ala Val Asp Gln Glu Leu Phe Asn Glu Tyr Gln Phe Ser Val 
65                  70                  75                  80  


Asp Gln Leu Met Glu Leu Ala Gly Leu Ser Cys Ala Thr Ala Ile Ala 
                85                  90                  95      


Lys Ala Tyr Pro Pro Thr Ser Met Ser Arg Ser Pro Pro Thr Val Leu 
            100                 105                 110         


Val Ile Cys Gly Pro Gly Asn Asn Gly Gly Asp Gly Leu Val Cys Ala 
        115                 120                 125             


Arg His Leu Lys Leu Phe Gly Tyr Glu Pro Thr Ile Tyr Tyr Pro Lys 
    130                 135                 140                 


Arg Pro Asn Lys Pro Leu Phe Thr Ala Leu Val Thr Gln Cys Gln Lys 
145                 150                 155                 160 


Met Asp Ile Pro Phe Leu Gly Glu Met Pro Ala Glu Pro Met Thr Ile 
                165                 170                 175     


Asp Glu Leu Tyr Glu Leu Val Val Asp Ala Ile Phe Gly Phe Ser Phe 
            180                 185                 190         


Lys Gly Asp Val Arg Glu Pro Phe His Ser Ile Leu Ser Val Leu Lys 
        195                 200                 205             


Gly Leu Thr Val Pro Ile Ala Ser Ile Asp Ile Pro Ser Gly Trp Asp 
    210                 215                 220                 


Val Glu Lys Gly Asn Ala Gly Gly Ile Gln Pro Asp Leu Leu Ile Ser 
225                 230                 235                 240 


Leu Thr Ala Pro Lys Lys Ser Ala Thr Gln Phe Thr Gly Arg Tyr His 
                245                 250                 255     


Tyr Leu Gly Gly Arg Phe Val Pro Pro Ala Leu Glu Lys Lys Tyr Gln 
            260                 265                 270         


Leu Asn Leu Pro Pro Tyr Pro Asp Thr Glu Cys Val Tyr Arg Leu Gln 
        275                 280                 285             


